Immunome (IMNM) Other Non-Current Assets (2019 - 2026)
Immunome (IMNM) recorded Other Non-Current Assets of $5.42 million in Q2 2026, compared with $210,000 a year earlier and up 1.1% from the prior quarter.
Powered by 
Analysis
Immunome (IMNM) Other Non-Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Immunome reported Other Non-Current Assets of $4.59 million, up 4.0% from FY2024.
- Annual Other Non-Current Assets has a five-year compound annual growth rate of 114.9% (FY2020 to FY2025).
- Across earlier years, Other Non-Current Assets came in at $4.41 million in FY2024, $100,000 in FY2023 (-69.9%), $332,000 in FY2022 (unchanged) and $332,000 in FY2021 (+232.0%).
- The Q2 2026 figure is the highest quarterly Other Non-Current Assets in data going back to Q4 2019.
- On a year-over-year basis, Other Non-Current Assets rose in two of the last four quarters, with growth averaging 28.5%.
- Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 232.0% in Q4 2021, against a decline of 69.9% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.36 million (Q1 2026), $4.59 million (Q4 2025) and $4.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Immunome | 2.20 Bn | 169.23 Mn | - | 5.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.63 Mn |
| Mar 31, 2026 | 5.57 Mn |
| Dec 31, 2025 | 4.80 Mn |
| Sep 30, 2025 | 4.77 Mn |
| Jun 30, 2025 | 210,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 4.51 Mn |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 432,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 432,000.00 |
| Sep 30, 2021 | 100,000.00 |
API Access
Immunome Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=IMNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "IMNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=IMNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();